Tecogen Valuation
| TGEN Stock | USD 8.35 0.04 0.48% |
At this time, the company appears to be overvalued. Tecogen has a current Real Value of $7.07 per share. The regular price of the company is $8.35. Our model measures the value of Tecogen from inspecting the company fundamentals such as Return On Equity of -0.0436, shares outstanding of 24.85 M, and Operating Margin of (0.03) % as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Tecogen's price fluctuation is risky at this time. Calculation of the real value of Tecogen is based on 3 months time horizon. Increasing Tecogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Tecogen otc stock is determined by what a typical buyer is willing to pay for full or partial control of Tecogen. Since Tecogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tecogen OTC Stock. However, Tecogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.35 | Real 7.07 | Hype 8.35 | Naive 8.29 |
The intrinsic value of Tecogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Tecogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Tecogen helps investors to forecast how Tecogen otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tecogen more accurately as focusing exclusively on Tecogen's fundamentals will not take into account other important factors: Tecogen Total Value Analysis
Tecogen is at this time forecasted to have valuation of 30.65 M with market capitalization of 29.07 M, debt of 1.64 M, and cash on hands of 2.83 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Tecogen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
30.65 M | 29.07 M | 1.64 M | 2.83 M |
Tecogen Investor Information
About 45.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tecogen had not issued any dividends in recent years. Based on the analysis of Tecogen's profitability, liquidity, and operating efficiency, Tecogen is not in a good financial situation at this time. It has a very high odds of going through financial crisis in August.Tecogen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Tecogen has an asset utilization ratio of 75.39 percent. This suggests that the OTC Stock is making $0.75 for each dollar of assets. An increasing asset utilization means that Tecogen is more efficient with each dollar of assets it utilizes for everyday operations.Tecogen Ownership Allocation
Tecogen shows a total of 24.85 Million outstanding shares. Tecogen maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tecogen Profitability Analysis
The company reported the previous year's revenue of 24.4 M. Net Income was 3.7 M with profit before overhead, payroll, taxes, and interest of 11.59 M.About Tecogen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Tecogen. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Tecogen based exclusively on its fundamental and basic technical indicators. By analyzing Tecogen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Tecogen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tecogen. We calculate exposure to Tecogen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tecogen's related companies.Tecogen Inc. designs, manufactures, markets, and maintains industrial and commercial cogeneration systems for residential, commercial, recreational, and industrial use in the United States and internationally. The company was incorporated in 2000 and is headquartered in Waltham, Massachusetts. Tecogen operates under Electrical Equipment Parts classification in the United States and is traded on OTC Exchange. It employs 77 people.
8 Steps to conduct Tecogen's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Tecogen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Tecogen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Tecogen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Tecogen's revenue streams: Identify Tecogen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Tecogen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Tecogen's growth potential: Evaluate Tecogen's management, business model, and growth potential.
- Determine Tecogen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Tecogen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Tecogen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 24.9 M | |
| Quarterly Earnings Growth Y O Y | -0.949 | |
| Forward Price Earnings | 101.0101 | |
| Retained Earnings | -35.8 M |
Other Information on Investing in Tecogen OTC Stock
Tecogen financial ratios help investors to determine whether Tecogen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tecogen with respect to the benefits of owning Tecogen security.